The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Dynamic changes in biomarkers for immune response to sipuleucel-t (SipT) for metastatic castrate-resistant prostate cancer (mCRPC).
 
Mehmet Faith Hepgur
No Relationships to Disclose
 
Tanya B. Dorff
Consulting or Advisory Role - Astellas Pharma; Dendreon; Janssen; Medivation
Speakers' Bureau - Astellas Pharma; Bayer; Pfizer; Sanofi
 
Jie Cai
No Relationships to Disclose
 
Mary Reed
No Relationships to Disclose
 
Betty Chan
No Relationships to Disclose
 
David I. Quinn
Honoraria - Algeta ASA; Astellas Pharma; Bayer; Bristol-Myers Squibb; Dendreon; Fresenius Kabi; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Consulting or Advisory Role - Algeta/Bayer; Astellas Pharma; Bristol-Myers Squibb; Dendreon; Genentech/Roche; Janssen Oncology; Medivation; Novartis; Pfizer
Research Funding - Genentech/Roche (Inst); GlaxoSmithKline (Inst); Millennium (Inst); Sanofi (Inst)
Expert Testimony - Medivation; Teva